Trump strikes MFN drug-pricing deals with 9 more drugmakers as Incyte joins quietly; Oz says 600K seniors signed up for CMS Bridge.
Company executives joined President Donald Trump and top health officials at a drug pricing event on Aug. 31, 2026 (Jacquelyn Martin/AP Images)
September 1, 2026 02:16 PM EDT
PharmaFDA+
Three takeaways from the latest White House drug pricing event
Max Bayer
Some four months after the White House inked the last of its expected drug pricing deals with 17 of the industry’s top players,…
Focused on Medicaid, the new pacts now involve more than just large pharmaceutical companies, but still aren’t expected to…
Nine more drugmakers strike voluntary drug-pricing deals with the White House, pledging nearly $20B in US investments to avoid…
The new agreements bring the total number of companies in the administration's most-favored-nation pricing program to 26
The deals will build on agreements the administration struck with 17 of the world’s largest drugmakers, including Pfizer, Eli…
The Trump administration is expected to announce voluntary drug-pricing agreements with midsize biotech companies, requiring…
